Remove 2018 Remove Competition Remove Healthcare
article thumbnail

Katie Porter attacks pharma

World of DTC Marketing

percent from 2018. The cost of bringing a drug to market decreased from $2,168 million in 2018 to $1,981 in 2019. The other key point is that Ms Porter misses entirely is that healthcare cots are being driven by a public that is obese and doesn’t exercise. In pharma R&D returns have declined to 1.8 percent per year.

Pharma 187
article thumbnail

PBMs and insurers want your prescription money

World of DTC Marketing

Those health insurers, in turn, use the discounts to offer more competitive premiums in a bid to attract enrollees. Drug non-adherence cost the country at least $495 billion and contributed to over 275,000 premature deaths in 2016, according to a 2018 study in The Annals of Pharmacotherapy. It isn’t very likely.

Insurance 226
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ten Ways to Think Differently About Small-to-Mid-Sized Pharma Launches

Eversana Intouch

By 2018, that share had fallen by about half. Meanwhile, the number of companies launching their first drug during the decade preceding 2018 more than tripled. Back in 2003, drugs from large pharma companies made up 36% of the late-stage R&D pipeline.

Pharma 105
article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. CVS’ bid for Oak Street is in keeping with nearly two decades of evolution toward becoming an integrated payer and provider.

article thumbnail

The importance of SDoH insights at the peak of healthcare consumerism

Clarify Health

As economic purchasing power and decision-making increasingly fall within the hands of patients, and as non-traditional healthcare providers, like Amazon and Walmart, push care into retail experiences, healthcare consumers are becoming more selective, and some may be more willing to “shop around” for health services.

article thumbnail

The EU HTA regulation: a new frontier for access to innovative technologies

European Pharmaceutical Review

1 The regulation is the culmination of a long debate between European Union (EU) Member States and health sector stakeholders, triggered by joint actions such as European Network for Health Technology Assessment (EUnetHTA) and formalised through the European Commission (EC)’s proposal in January 2018. governmental healthcare organisations.

article thumbnail

What to expect in the new era of healthcare price transparency

Clarify Health

Healthcare price transparency continues to grow, with health insurers required to release cost-sharing estimates beginning in 2022. What’s new for healthcare price transparency in 2021 ? The American healthcare system is ushering in a new era of health cost transparency. Why is price transparency important in healthcare?